How do we test how environmental, social, and governance (ESG) investing returns compare to those of similar traditional investments? The simplest way is to look at bonds.

20 August 2019

The Fed Has Few Options, Says Danielle DiMartino Booth

By Peter M.J. Gross

“You don’t have a lot to work with when the next discussion around the table is negative interest rates,” says Danielle DiMartino Booth.

05 August 2019

Edward Altman: Where Are We in the Credit Cycle?*

By Edward Altman

Has the bubble in credit markets achieved new momentum? Edward Altman weighs in.

19 July 2019

Book Review: Bond Pricing and Yield Curve Modeling

By Mark K. Bhasin, CFA

Riccardo Rebonato combines theory with current empirical evidence to build a robust understanding of what drives the government bond market.

Curated Global Headlines by SmartBrief.com

Bailey: BoE won't risk inflation to beat coronavirus

The Bank of England will not resort to printing money to lessen the economic impact of the coronavirus pandemic, Governor Andrew Bailey says. "Using monetary financing would damage credibility on controlling inflation by eroding operational independence," Bailey says. Reuters (05 Apr.)

SEC's Lee calls for rule changes to be postponed

Securities and Exchange Commission member Allison Herren Lee wants the agency to pause pending rule changes but not rush into regulatory relief without analysis amid the coronavirus pandemic. "Relevant considerations in that analysis include whether an action is directly responsive to COVID-19 and whether an action represents an appropriate use of agency resources at a time when we are routinely called upon to take emergency actions," she says. Reuters (04 Apr.)

FDA's Hahn: China not causing US drug shortage

If the US has any shortage of drugs, it is because of high demand and not because China or any other country is preventing the supply of ingredients, says Stephen Hahn, head of the US Food and Drug Administration. "We don't have any evidence that there is a drug in short supply because of anyone blocking the active pharmaceutical ingredients in the drugs," he says. BNN Bloomberg (Canada) (05 Apr.)

More Headlines